These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32223656)

  • 1. Beyond type 2 cytokines in asthma - new insights from old clinical trials.
    Choy DF; Arron JR
    Expert Opin Ther Targets; 2020 May; 24(5):463-475. PubMed ID: 32223656
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
    Shum BO; Rolph MS; Sewell WA
    Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining approaches to asthma: developing targeted biologic therapies.
    Arron JR; Scheerens H; Matthews JG
    Adv Pharmacol; 2013; 66():1-49. PubMed ID: 23433454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Molecular Knowledge of Therapeutic Drugs and Natural Products Focusing on Inflammatory Cytokines in Asthma.
    Lin SC; Shi LS; Ye YL
    Cells; 2019 Jul; 8(7):. PubMed ID: 31284537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IL-4/-13 based therapy in asthma.
    Walsh GM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the role of cytokines in asthma.
    Renauld JC
    J Clin Pathol; 2001 Aug; 54(8):577-89. PubMed ID: 11477111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Targeted Therapies for Uncontrolled Asthma.
    Corren J
    J Allergy Clin Immunol Pract; 2019; 7(5):1394-1403. PubMed ID: 31076057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of targeting interleukin 5 in asthma.
    Walsh GM
    BioDrugs; 2013 Dec; 27(6):559-63. PubMed ID: 23728885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted anti-IL-13 therapies in asthma: current data and future perspectives.
    Ntontsi P; Papathanassiou E; Loukides S; Bakakos P; Hillas G
    Expert Opin Investig Drugs; 2018 Feb; 27(2):179-186. PubMed ID: 29334288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and anti-cytokine therapy in asthma: ready for the clinic?
    Desai D; Brightling C
    Clin Exp Immunol; 2009 Oct; 158(1):10-9. PubMed ID: 19737225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research on inflammatory mediators in asthma: new therapeutic approaches].
    Magnan A; Molimard M; Braunstein G; Devillier P
    Therapie; 1999; 54(4):447-61. PubMed ID: 10667111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma.
    Mitchell PD; El-Gammal AI; O'Byrne PM
    Clin Pharmacol Ther; 2016 Jan; 99(1):38-48. PubMed ID: 26502193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversion of Asthmatic Complications and Mast Cell Signalling Pathways in BALB/c Mice Model Using Quercetin Nanocrystals.
    Gupta K; Kumar S; Gupta RK; Sharma A; Verma AK; Stalin K; Chaudhari BP; Das M; Singh SP; Dwivedi PD
    J Biomed Nanotechnol; 2016 Apr; 12(4):717-31. PubMed ID: 27301198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells.
    Terashita T; Kobayashi K; Nagano T; Kawa Y; Tamura D; Nakata K; Yamamoto M; Tachihara M; Kamiryo H; Nishimura Y
    Respir Res; 2016 Nov; 17(1):146. PubMed ID: 27829417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cytokines of Asthma.
    Lambrecht BN; Hammad H; Fahy JV
    Immunity; 2019 Apr; 50(4):975-991. PubMed ID: 30995510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophils and mast cells in airway inflammation and asthma.
    Denburg JA
    Can Respir J; 1998; 5 Suppl A():41A-4A. PubMed ID: 9753516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Anti-Cytokine Strategies for Prevention and Treatment of Respiratory Allergic Diseases.
    Gubernatorova EO; Namakanova OA; Gorshkova EA; Medvedovskaya AD; Nedospasov SA; Drutskaya MS
    Front Immunol; 2021; 12():601842. PubMed ID: 34084159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of biologics targeting type 2 airway inflammation in asthma: what have we learned so far?
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2017 Jan; 23(1):3-11. PubMed ID: 27820746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.
    Godar M; Blanchetot C; de Haard H; Lambrecht BN; Brusselle G
    MAbs; 2018 Jan; 10(1):34-45. PubMed ID: 29035619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.